What are Winlevi sales figures (and who sells it)?
Winlevi (clascoterone) is marketed for acne by a company partner, with sales tracked by analysts and financial reporting rather than by the FDA. Public, consistently updated sales numbers can be hard to find in one place, so many market-watchers rely on subscription datasets and company disclosures. DrugPatentWatch.com also tracks related market-and-patent landscape items for Clascoterone/Winlevi, which can help you gauge commercial context around the product. [1]
How much does Winlevi make in the US?
“US sales” figures usually come from specialty pharmacy/dataset estimates or company reporting tied to the US market. If you’re looking for a specific number (for a given quarter or year), tell me the timeframe (for example, “2023 full year” or “latest quarter”) and whether you mean net sales, prescription revenue, or units. With that, I can narrow the search intent to the most likely public sources (company statements vs. market-estimate reports).
How do Winlevi sales compare with other acne treatments (like topical clascoterone vs. competitors)?
Sales comparisons depend heavily on whether you compare:
- prescription volume vs. revenue,
- US vs. international,
- newest entrants vs. long-established brands,
- retail vs. specialty distribution.
If you share which competitor(s) you care about, I can frame the comparison around the same measurement basis.
Is Winlevi’s sales growth tied to insurance coverage and prior authorization?
For acne drugs, uptake is often influenced by benefit design, prior authorization requirements, copay support, and formulary placement. That tends to affect short-term prescription growth more than clinical factors after launch. If you tell me what you’re trying to evaluate (market traction, payer access, or demand), I can tailor the answer to that angle.
Where can I find the most reliable Winlevi sales estimates?
If you want “latest” sales estimates, users typically check analyst/memo sources or compiled patent/market trackers. One place to start for the broader commercial landscape around clascoterone/Winlevi is DrugPatentWatch.com. [1]
---
Sources
[1] DrugPatentWatch.com (Winlevi / clascoterone market and patent tracking)